Diseases, Conditions, Syndromes

Malaria testing yet to reach its potential

In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across ...

Diseases, Conditions, Syndromes

Stressed-out parasites: Overcoming drug-resistant malaria

Drug resistance to the critical antimalarial therapeutics of the artemisinin family has emerged in Southeast Asia, highlighting the need to understand how these drugs work and how they can be used more effectively. Research ...

Diseases, Conditions, Syndromes

Malaria: a new treatment to slow down resistance

The appearance of malaria parasites resistant to medicines is one of the main obstacles in combating the disease. In order to slow down this phenomenon, it is essential to avoid exposing the pathogen to the same molecules. ...

Diseases, Conditions, Syndromes

Text message service aids malaria care

A mobile phone text message reminder service has proved to be a successful way of ensuring health workers stick to new protocols for malaria in Papua New Guinea.

Diseases, Conditions, Syndromes

Pregnant women are often given inappropriate treatment for malaria

Not all pregnant women with symptoms of malaria seek care from their formal healthcare system and if they do seek care, they may be given inappropriate treatment because healthcare providers often fail to adhere to the standard ...

Diseases, Conditions, Syndromes

Cochrane Review on primaquine to prevent malaria transmission

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of adding a single dose of primaquine (PQ) to malaria treatment to prevent the transmission of the disease.

Diseases, Conditions, Syndromes

Simple, rapid test for drug-resistant malaria developed

For the first time, scientists have developed a novel and rapid way to test whether the most common and lethal form of malaria is resistant to potent artemisinin drugs.

page 3 from 6